198 related articles for article (PubMed ID: 2049749)
21. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma. A French experience.
Grassin F; Paleiron N; André M; Caliandro R; Bretel JJ; Terrier P; Margery J; Le Chevalier T; Ruffié P
J Thorac Oncol; 2010 Jun; 5(6):893-7. PubMed ID: 20521356
[TBL] [Abstract][Full Text] [Related]
22. [The usefulness of induction chemotherapy in cases with tumors showing border-line pathological aspects between thymoma and thymic carcinoma].
Nonami Y; Moriki T; Yamamoto A; Yamashiro T; Sasaguri S; Nakata H; Kobayashi M
Kyobu Geka; 2002 Oct; 55(11):953-8. PubMed ID: 12391692
[TBL] [Abstract][Full Text] [Related]
23. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
[TBL] [Abstract][Full Text] [Related]
24. [A case of invasive thymoma made resectable by preoperative chemotherapy].
Tanaka K; Murota Y; Ando T; Asano K; Yamaguchi T; Wada G
Kyobu Geka; 1996 Sep; 49(10):868-71. PubMed ID: 8828336
[TBL] [Abstract][Full Text] [Related]
25. Treatment of invasive thymoma with single-agent ifosfamide.
Highley MS; Underhill CR; Parnis FX; Karapetis C; Rankin E; Dussek J; Bryant B; Rowland C; Hodson N; Hughes J; Harper PG
J Clin Oncol; 1999 Sep; 17(9):2737-44. PubMed ID: 10561348
[TBL] [Abstract][Full Text] [Related]
26. Multidisciplinary therapy including high-dose chemotherapy followed by peripheral blood stem cell transplantation for invasive thymoma.
Iwasaki Y; Ohsugi S; Takemura Y; Nagata K; Harada H; Nakagawa M
Chest; 2002 Dec; 122(6):2249-52. PubMed ID: 12475873
[TBL] [Abstract][Full Text] [Related]
27. [Medical treatment for thymoma: an update].
Lalle M; Bellini V; Antimi M
Clin Ter; 2008; 159(2):91-5. PubMed ID: 18463767
[TBL] [Abstract][Full Text] [Related]
28. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
[TBL] [Abstract][Full Text] [Related]
29. A phase-II trial of dose-dense chemotherapy in patients with disseminated thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9605).
Kunitoh H; Tamura T; Shibata T; Nakagawa K; Takeda K; Nishiwaki Y; Osaki Y; Noda K; Yokoyama A; Saijo N;
Br J Cancer; 2009 Nov; 101(9):1549-54. PubMed ID: 19809436
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy of malignant thymoma. Case report and review of the literature.
Hu E; Levine J
Cancer; 1986 Mar; 57(6):1101-4. PubMed ID: 3080220
[TBL] [Abstract][Full Text] [Related]
31. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
[TBL] [Abstract][Full Text] [Related]
32. [Chemotherapy of thymoma].
Monden Y; Uyama T; Kimura S; Takahashi K
Gan To Kagaku Ryoho; 1990 Oct; 17(10):2019-24. PubMed ID: 2221924
[TBL] [Abstract][Full Text] [Related]
33. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
[TBL] [Abstract][Full Text] [Related]
34. Atypical thymoma: a report of seven patients.
Baran JL; Magro CM; King MA; Williams TE; Ross P
Ann Thorac Surg; 2004 Aug; 78(2):411-6. PubMed ID: 15276487
[TBL] [Abstract][Full Text] [Related]
35. Objective response to epirubicin and lonidamine. A case of advanced thymoma previously treated with the ADOC scheme and unresponsive to paclitaxel plus cyclophosphamide.
Berruti A; Tampellini M; Gorzegno G; Dogliotti L
Chest; 1997 May; 111(5):1473-4. PubMed ID: 9149629
[No Abstract] [Full Text] [Related]
36. Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Fédération Nationale des Centres de Lutte Contre le Cancer.
Mornex F; Resbeut M; Richaud P; Jung GM; Mirabel X; Marchal C; Lagrange JL; Rambert P; Chaplain G; Nguyen TD
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):651-9. PubMed ID: 7790251
[TBL] [Abstract][Full Text] [Related]
37. High-dose carboplatin with etoposide in patients with recurrent thymoma: the Indiana University experience.
Hanna N; Gharpure VS; Abonour R; Cornetta K; Loehrer PJ
Bone Marrow Transplant; 2001 Sep; 28(5):435-8. PubMed ID: 11593315
[TBL] [Abstract][Full Text] [Related]
38. [Surgical treatment of thymoma--clinical evaluation].
Ietsugu K; Shimizu J; Murakami S; Oda M; Hayashi Y; Tatsuzawa Y; Kobayashi K; Sekido N; Arano Y; Takahashi A
Kyobu Geka; 1993 Jan; 46(1):4-8. PubMed ID: 8418358
[TBL] [Abstract][Full Text] [Related]
39. Retreatment of recurrent invasive thymoma with platinum, doxorubicin, and cyclophosphamide.
Lara PN; Bonomi PD; Faber LP
Chest; 1996 Oct; 110(4):1115-7. PubMed ID: 8874280
[TBL] [Abstract][Full Text] [Related]
40. High-dose adriamycin (ADM) and cis-platinum (DDP) in advanced soft-tissue sarcomas and invasive thymomas. A pilot study.
Klippstein TH; Mitrou PS; Kochendörfer KJ; Bergmann L
Cancer Chemother Pharmacol; 1984; 13(2):78-81. PubMed ID: 6540630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]